March 13, 2020 / 11:42 AM / 15 days ago

BRIEF-Applied Therapeutics Says Cash And Cash Equivalents And Short-Term Investments Totaled $38.9 Mln As Of December 31, 2019

March 13 (Reuters) - Applied Therapeutics Inc:

* APPLIED THERAPEUTICS REPORTS FOURTH QUARTER AND YEAR-END 2019 FINANCIAL RESULTS

* APPLIED THERAPEUTICS - CASH AND CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS TOTALED $38.9 MILLION AS OF DECEMBER 31, 2019

* APPLIED THERAPEUTICS - “ON DIABETIC CARDIOMYOPATHY PROGRAM, REMAIN ON TRACK TO FULLY ENROLL OUR PHASE 3 REGISTRATIONAL STUDY THIS YEAR”

* APPLIED THERAPEUTICS- PLAN TO MOVE QUICKLY TOWARDS REGULATORY FILING FOR GALACTOSEMIA, WHILE PREPARING FOR ITS COMMERCIAL LAUNCH Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below